New strategies for a better use of peginterferon and ribavirin and new drugs with specifically-targeted antiviral therapy for chronic hepatitis C
Muñoz, A.E.
Acta Gastroenterologica Latinoamericana 37(2): 126-133
2007
ISSN/ISBN: 0300-9033 PMID: 17684944 Document Number: 609722
Document emailed within 1 workday
Related Documents
Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111Roznovský, L.; Orságová, I.; Petrousová, L.; Mrázek, J.; Kloudová, A.; Kabieszová, L.; Kůrková, J.; Pospísek, M. 2010: Retreatment with peginterferon plus ribavirin in chronic hepatitis C patients: our own experiences Klinicka Mikrobiologie a Infekcni Lekarstvi 16(2): 73-75
Varghese, R.; Al-Khaldi, J.; Asker, H.; Fadili, A.A.; Al Ali, J.; Hassan, F.A. 2009: Treatment of chronic hepatitis C genotype 4 with peginterferon alpha-2a plus ribavirin Hepato-Gastroenterology 56(89): 218-222
Yu, J.; Liu, B.-w.; Lan, L.; Yuan, Y.; Zhang, H.; Jia, C.-h. 2010: Efficacy of peginterferon alpha-2a in combination with ribavirin in treatment of eldly patients with chronic hepatitis C Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 24(5): 373-375
Bizid, S.; Ben Abdallah, H.; Kilani, I.; Mohamed, G.; Bouali, R.; Abdelli, N. 2013: Predictive factors of response to peginterferon and ribavirin in Tunisians patients with chronic hepatitis C: report of 141 cases La Tunisie Medicale 91(5): 327-331
Taskoparan, M.; Serin, E.; Gokturk, H.Savas.; Icer, M.Okan.; Abaci, K.; Ozer, B.; Zumrutdal, A.; Yilmaz, U. 2011: Early effect of peginterferon alpha-2b plus ribavirin treatment on blood pressure and insulin resistance in patients with chronic hepatitis C Hepato-Gastroenterology 58(107-108): 875-879
Ayyub, M.A.; El-Moursy, S.A.; Khazindar, A.M.; Abbas, F.A. 2009: Successful treatment of chronic hepatitis C virus infection with peginterferon alpha-2a and ribavirin in patients with sickle cell disease Saudi Medical Journal 30(5): 712-716
Abramowicz, M. 2007: Peginterferon and ribavirin for hepatitis C New England Journal of Medicine 356(12): 1270-1271; Author Reply 1271
Nevens, F.; Van Vlierberghe, H.; D'Heygere, E.; Delwaide, J.; Adler, M.; Henrion, J.; Lenaerts, A.; Hendlisz, A.; Michielsen, P.; Bastens, B.; Brenard, R.; Laureys, A. 2010: A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients Acta Gastro-Enterologica Belgica 73(2): 223-228
Nunnari, G.; Montineri, A.; Portelli, V.; Savalli, F.; Fatuzzo, F.; Cacopardo, B. 2012: The use of peginterferon in monotherapy or in combination with ribavirin for the treatment of acute hepatitis C European Review for Medical and Pharmacological Sciences 16(8): 1013-1016
Jurczyk, K.; Karpińska, E.; Wawrzynowicz-Syczewska, M.; Morańska, I.; Noceń, I.; Chlubek, D.; Boroń-Kaczmarska, A. 2008: State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin Hepato-Gastroenterology 55(82-83): 557-561
Gheorghe, L.; Baculea, S. 2010: Cost-effectiveness of peginterferon alpha-2a and peginterferon alpha-2b combination regimens in genotype-1 naive patients with chronic hepatitis C Hepato-Gastroenterology 57(101): 939-944
Takagi, H.; Hoshino, T.; Naganuma, A.; Koitabashi, E.; Uehara, S.; Sakamoto, N.; Kudo, T.; Ryusaki, K.; Kakizaki, S.; Okamoto, H. 2013: Drug induced hypersensitivity syndrome by triple therapy of peginterferon alpha2b, ribavirin and telaprevir in patient with double positive for HBV and HCV Hepato-Gastroenterology 60(127): 1557-1560
Arase, Y. 2011: Combination therapy of PEG-interferon and ribavirin for chronic hepatitis C in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 191-195
Gunsar, F.; Akarca, U.S.; Ersoz, G.; Kobak, A.C.; Karasu, Z.; Yuce, G.; Ilter, T.; Batur, Y. 2005: Two-year interferon therapy with or without ribavirin in chronic delta hepatitis Antiviral Therapy 10(6): 721-726
Sajjad, S.F.; Ahmed, W.u.; Arif, A.; Alam, S.E.; Waquar, J. 2012: Weight loss with interferon and ribavirin therapy in chronic hepatitis C patients JPMA. Journal of the Pakistan Medical Association 62(11): 1229-1232
Marcellin, P.; Lada, O. 2006: Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B Gastroenterologie Clinique et Biologique 30(10 Part 2): 3s5-3s8
Ferenci, P. 2006: Pegylated interferon plus ribavirin for chronic hepatitis C: the role of combination therapy today, tomorrow and in the future Minerva Gastroenterologica e Dietologica 52(2): 157-174
Vashakidze, E.; Imnadze, T. 2017: Combined Antiviral Treatment of Hepatitis C Virus Infection with Pegylated Interferon (Peg-Ifn) Α-2a (Pegferon) and Ribavirin (Copegus) in Inmates Georgian Medical News 264: 86-90
Geller, L.I. 1990: Antiviral preparations in the therapy of chronic viral hepatitis Terapevticheskii Arkhiv 62(11): 15-19